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The Core Outcome Measures in Effectiveness Trials (COMET) Initiative database is an international repository of
studies relevant to the development of core outcome sets. By the end of 2013, it included a unique collection of
306 studies. The website is increasingly being used, with more than 12,000 visits in 2013 (a 55% increase over 2012),
8,369 unique visitors (a 53% increase) and 6,844 new visitors (a 48% increase). There has been a rise in visits from
outside the United Kingdom, with 2,405 such visits in 2013 (30% of all visits). By December 2013, a total of 4,205
searches had been completed, with 2,139 in 2013 alone.
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Background
In January 2014, The Lancet published a series of papers
addressing the important issue of waste in research that
may be due to important outcomes not being assessed
[1] or to selective reporting of outcomes [2]. Selective
reporting or nonreporting of studies and outcomes may
mean that decisions made about health care and research
design may not be fully informed, which in turn may lead
to wasting of valuable health-care resources. The Core
Outcome Measures in Effectiveness Trials (COMET) Ini-
tiative was set up to try to improve the usefulness of
outcomes in research and to tackle these problems [3].
COMET brings together people interested in the deve-
lopment, reporting and application of core outcome sets
(COSs). These sets represent the minimum that should be
measured and reported in all clinical trials of a specific
condition and are also suitable for use in other types of re-
search and clinical audit [4]. The expectation is that the
core outcomes will always be collected and reported and
that researchers might also include other outcomes of par-
ticular relevance to their specific study. The existence or
use of a COS does not imply that outcomes in a particular
trial should be restricted to those in the relevant set. The
use of COSs will make it easier for the results of trials to* Correspondence: e.gargon@liv.ac.uk
1University of Liverpool, Department of Biostatistics, 1st floor Duncan
Building, Daulby Street, Liverpool L69 3GA, UK
Full list of author information is available at the end of the article
© 2014 Gargon et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.be compared, contrasted and combined as appropriate,
thereby reducing waste in research.
The members of the COMET Initiative aim to collate
and stimulate relevant resources (both applied and me-
thodological), to facilitate the exchange of ideas and in-
formation and to foster methodological research in the
area of COSs by bringing relevant material together, thus
making it more accessible. For COSs to be an effective
solution, they need to be easily accessible by researchers
and other key groups. To date, however, it has been dif-
ficult to identify COSs because they are hard to find in
the literature. This may mean that they are not used in
new studies or that there is unnecessary duplication of
effort in developing new COSs. The COMET Initiative
seeks to tackle this problem and to reduce the possibility
of waste in research by bringing these resources together
in one place [5]. The types of studies included in the
database are those in which COSs have been developed,
as well as studies relevant to COS development, includ-
ing systematic reviews of outcomes and patients’ views.
Individuals and groups who are planning or developing
a COS, who have completed one or who have identified
one in an ad hoc way can submit it for inclusion. The
website and database were launched in August 2011, and
in this letter we outline activities and progress related to
the COMET website and database up to 31 December
2013 (source of data usage: Google Analytics). We provide
data on the value and use of the COMET materials, as
well as interest in COSs, above and beyond what might beLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Activity and content
On 31 December 2013, a total of 306 studies relevant to
the development of COS were included in the COMET
database, up from 189 at the end of the previous year.
The total at the end of 2013 included 48 planned and
ongoing studies, up from 23 at the end of 2012. Since
the launch of the database, there has been a rapid in-
crease in the number of users of the website and da-
tabase. Usage statistics show that the number of visits
increased from 7,982 during 2012 to 12,332 in 2013, a
55% increase. The number of unique visitors similarly
increased (by 53%), from 5,471 in 2012 to 8,369 in 2013,
and the number of new visitors also increased (by 48%),
from 4,611 in 2012 to 6,844 in 2013. Full details of the
breakdown of these statistics are provided in Table 1.
Usage statistics show that, from inception to 31 Decem-
ber 2013, there were almost 100,000 page views, with a
66% increase seen from 2012 to 2013 (from 32,117 to
53,226 page views). By December 2013, a total of 4,205
searches of the database had been run, with 2,139 in 2013
alone—an increase of one-third compared to 1,597 sear-
ches in 2012. Cumulative totals are shown in Figure 1.
This growth in use suggests that the COMET website and
database are gaining interest, acceptance and prominence
and that there is a growing awareness of the COMET
Initiative.
The majority of visits to the website were direct or via
a search engine. Sixteen percent of all visits were re-
ferrals, including Twitter (14%), MRC Network of Hubs
for Trials Methodology Research (7%), the CochraneTable 1 Usage statistics, 2011 through 2013
Number of visits Numbe
Month 2011 2012 2013 2011
January – 670 1069 –
February – 762 1017 –
March – 649 1238 –
April – 683 1050 –
May – 659 1088 –
June – 435 1403 –
July – 472 945 –
August 804 457 833 503
September 448 483 901 314
October 460 669 984 295
November 686 1117 966 484
December 580 926 838 409
Totals 2,978 7,982 12,332 2,005Collaboration (The Cochrane Library (5%) and the www.
cochrane.org website (4%)), the EQUATOR Network
(3%), the National Institute for Health Research (2%),
BMJ blogs (2%) and the SPIRIT statement website (2%).
Analyses of the website data show that half of the visi-
tors went beyond the page on which they landed and
that the most common interaction in both 2012 and
2013 was to complete a search in the COMET database.
Other first interactions included moving to the page
that provides an overview of the COMET Initiative,
accessing the database but without completing a search
and visiting the pages containing details of the COMET
II or COMET III meeting or collated resources about
COMET.
The number of countries in which visitors accessed the
website increased from a total of 66 in 2011, to 93 in 2012
and to 113 in 2013. This increase in the international
usage of the website and database is also reflected in the
number of visits. In 2012, 70% of the visits (n = 5,577)
were in the United Kingdom, 10% were in the United
States and Canada (n = 757) and the remaining 20% were
in other countries. In 2013, the percentage of visits in the
United Kingdom decreased to 59% (7,256 of the 12,332
total visits), increased to 12% in the United States and
Canada and increased to an aggregate 29% in all other
countries. Figure 2 shows the global distribution of total
visits up to 31 December 2013. This increase in the num-
ber of visits in countries outside the United Kingdom
reinforces COMET as an international initiative and
demonstrates increased global awareness of and inter-
est in COSs and the COMET Initiative. Currently, all
content and materials available on the website are
provided in the English language only.r of unique visitors Number of new visitors
2012 2013 2011 2012 2013
450 657 – 385 542
463 648 – 378 525
429 761 – 358 617
466 678 – 395 564
407 721 – 330 504
305 887 – 260 703
314 650 – 241 526
324 576 494 273 480
347 623 286 288 524
516 802 258 441 689
854 727 437 757 619
596 639 363 505 551
5,471 8,369 1,838 4,611 6,844
Figure 1 Cumulative number of completed searches in the Core Outcome Measures in Effectiveness Trials (COMET) Initiative database.
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pleted in the database from its launch in August 2011 to
December 2013. The search allows the user to take a
structured approach to finding COS. The most frequently
applied search criteria were disease category (81%), di-
sease name (69%), status of COS (53%), methods used
(29%), stakeholders involved (24%) and type of inter-
vention (20%). The most commonly searched terms were
cancer (n = 256), consensus (n = 218) and mental health
(n = 204).Figure 2 Visits to the Core Outcome Measures in Effectiveness Trials
December 2013, highlighting those with 100+ visits.Plans for the future
Several processes are underway to ensure that the COMET
database is comprehensive and up-to-date. Individuals and
groups who are planning or developing a COS can con-
tinue to submit it for inclusion. A systematic review de-
signed to identify studies was recently completed and
published [6]. This review involved extensive searches of
the health literature to identify studies in which the inves-
tigators sought to determine which outcomes or domains
to measure in all clinical trials of a specific condition.(COMET) Initiative website by country from August 2011 to
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database are being added to it (and thus did not contrib-
ute to the number of studies reported here), and an annual
search of the literature will take place to keep the database
current. We are also planning a review of methodological
papers to include in the COMET database. The content of
the website will continue to be updated regularly, and
we plan to extend the patient and public involvement
resources on the website beyond the plain language
summary that is currently available. We will continue
to increase awareness outside the United Kingdom at
meetings in Europe and the United States. The next
COMET meeting (COMET IV) will be held in Rome
later this year. Growing awareness of the need for COSs
and increased knowledge of the COMET Initiative should
continue to be reflected in the website and database usage
figures, which will continue to be monitored and assessed
annually.
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